LegalWork lawyers have been advising Immunovia
The Lund-based cancer diagnosis company Immunovia AB and the Knight Cancer Institute at Oregon Health & Science University (OHSU) has formed a collaboration to confirm, validate and commercialize a blood test for the early diagnosis of pancreatic cancer. The test called IMMray™ PanCan-d analyses a patient’s immune system for early signs of disease. The collaboration will also enable researchers to explore biomarkers for a number of other cancer types.
The contractual support to Immunovia were provided through a support team consisting of Leif Gallo and Ulf Lindén.
For more information:
Ulf Lindén, CEO LegalWorks